Tonix Pharmaceuticals Holding Corp. has entered into an Asset Purchase Agreement with Upsher Smith Laboratories, LLC to acquire assets related to Zembrace SymTouch and Tosymra products for $15 million in cash, with additional earn-out payments based on net sales.